4//SEC Filing
Simon Barry J. 4
Accession 0001326110-25-000006
CIK 0001326110other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 8:47 PM ET
Size
7.4 KB
Accession
0001326110-25-000006
Insider Transaction Report
Form 4
Simon Barry J.
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2025-01-22−110,020→ 0 totalExercise: $2.00Exp: 2025-02-16→ Common Stock (110,020 underlying) - Exercise/Conversion
Common Stock
2025-01-22$2.00/sh+110,020$219,864→ 3,233,781 total
Footnotes (2)
- [F1]Cash exercise of options scheduled to expire on February 16, 2025.
- [F2]Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option vested each month on the same day as the vesting commencement date, such that the shares subject to the option became fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option was January 16, 2015.
Documents
Issuer
ImmunityBio, Inc.
CIK 0001326110
Entity typeother
Related Parties
1- filerCIK 0001647994
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 8:47 PM ET
- Size
- 7.4 KB